Search by property

Jump to navigation Jump to search

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

Search by property

A list of all pages that have property "AnswerA" with value "Increase the dose of medication". Since there have been only a few results, also nearby values are displayed.

Showing below up to 26 results starting with #1.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)


    

List of results

  • WBR0680  + (IL-8)
  • WBR0378  + (IV antihistamine)
  • WBR1090  + (IV atropine)
  • WBR0372  + (IV benzodiazepines)
  • WBR0853  + (IV nafcillin for 4-6 weeks)
  • WBR0794  + (Ibuprofen)
  • WBR0440  + (Idiopathic hypertension)
  • WBR271  + (Idiopathic thrombocytopenic purpura)
  • WBR0476  + (IgG antibodies against cadherins)
  • WBR0872  + (IgG, C3 and C4 deposits)
  • WBR1044  + (IgM intercellular junctions of epidermal cells)
  • WBR0636  + (Imipenem/cilastatin)
  • WBR0356  + (Immediately start thrombolysis)
  • WBR0228  + (Immobilization)
  • WBR0960  + (Immune thrombocytopenia purpura)
  • WBR0328  + (Inability to laterally flex the neck)
  • WBR0426  + (Inability to tolerate normal sounds)
  • WBR0054  + (Inactivation of 60S ribsosome by cleaving rRNA)
  • WBR0536  + (Inactivation of dopamine receptors)
  • WBR0214  + (Inappropriate ADH secretion)
  • WBR0327  + (Increase in HbF levels)
  • WBR0580  + (Increase in arterial pCO2 only)
  • WBR0516  + (Increase in filtration fraction, increase in glomerular filtration rate and decrease in renal plasma flow)
  • WBR0467  + (Increase in fluid secretion in the small bowel lumen due to decreased absorption of electrolytes with stool osmolal gap < 50 mOsm/kg.)
  • WBR295  + (Increase of intracellular cyclic GMP)
  • WBR0182  + (Increase the dose of medication)
  • WBR0537  + (Increased HR, increased BP, increased CBF, and increased BDm)
  • WBR0648  + (Increased hemoglobin breakdown)
  • WBR0649  + (Increased hemoglobin breakdown)
  • WBR0421  + (Increased hepatocyte production of LDL-C)
  • WBR0431  + (Increased left ventricular (LV) preload due to left ventricular failure post-MI)
  • WBR0616  + (Increased lymphocytes, Increased red blood cells)
  • WBR0864  + (Increased oxygen consumption)
  • WBR0264  + (Increasing the evening dose of NPH insulin further)
  • WBR0919  + (Increasing the evening dose of NPH insulin further)
  • WBR0195  + (Increasing the evening dose of insulin)
  • WBR0920  + (Increasing the evening dose of insulin)
  • WBR0175  + (Inflammation exclusive to the duodenum)
  • WBR0161  + (Inflammatory arthritis due to deposition of monosodium urate)
  • WBR0156  + (Infliximab)
  • WBR0409  + (Influenza vaccination)
  • WBR0552  + (Infraspinatus)
  • WBR0807  + (Inguinal ligament)
  • WBR0056  + (Inhibition of attachment of aminoacyl-tRNA)
  • WBR0349  + (Inhibition of epoxide reductase)
  • WBR0434  + (Inhibition of heme polymerase activity)
  • WBR0164  + (Inhibits DNA and RNA synthesis by cross-linking DNA strands and causing strand breaks)
  • WBR0157  + (Inhibits dihydrofolate reductase)
  • WBR0252  + (Inhibits ergosterol synthesis)
  • WBR0165  + (Inhibits microtubule polymerization)
  • WBR0478  + (Inhibits squalene epoxidase)